Further reading on observed adverse signal profiles from the investigational phase 2 programme is available in the Retatrutide Side Effects: Detailed Guide with Clinical Trial Insights 2026 article, which summarises published tolerability data for research planning purposes
Hays KE, Pfaffinger JM, Ryznar R (2024) The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease
Traditionally, infusions derived from the aerial components of the plant are employed to remedy several health issues, including gastrointestinal diseases such as gastritis, colitis, ulcers, hepatitis, and cirrhosis, in addition to renal disorders
Many women struggle with weight loss not just because of eating habits, but due to thyroid dysfunction, insulin resistance, or hormonal imbalances that need to be addressed alongside GLP-1/GIP therapy